A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study.

Sarah VerrecchiaFredéric ChiambarettaLaurent KodjikianYasemin NakouriHussam El ChehabThibaud MathisYannis BadriRoman ChudzinskiAntoine LevronMayeul ChaperonEmilie AgardPierre PradatCorinne Dot

Published in: Acta ophthalmologica (2021)

Our results confirm the impairment of the ocular surface and quality of life immediately after an IVTI. These results suggest 3 levels of action to improve the immediate tolerance: improving the basal status of the ocular surface, reducing the contact time with povidone-iodine that might be toxic to the surface, and improving immediate post-IVTI treatment.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
vascular endothelial growth factor
magnetic resonance imaging
magnetic resonance
platelet rich plasma
endothelial cells
combination therapy
ultrasound guided